FDA targets misleading supplement labels

The FDA unveiled a new set of regulations calling for supplement companies to offer "competent and reliable scientific evidence" for health claims made on packages. The move was spurred by recent health concerns surrounding two popular supplements, ephedra and androstenedione, which have already been removed from store shelves.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD